Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery
Study Details
Study Description
Brief Summary
Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: P group Palonosetron group |
Drug: palonosetron
|
Experimental: PD group Palonosetron and dexamethasone group |
Drug: palonosetron with dexamethasone
|
Outcome Measures
Primary Outcome Measures
- incidence of clinically significant PONV with PONV impact scale [72 hours]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients who are undergoing minor orthopedic surgery.
-
IV patient controlled analgesia
Exclusion Criteria:
-
- minority (0~19 year)
-
patients who are belongs to ASA class 3 or more, and have underlying complicated cardiovascular or psychological disease.
-
Steroid medication
-
Diabetes Mellitus medication
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine | Seoul | Korea, Republic of | 03722 |
Sponsors and Collaborators
- Yonsei University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- 4-2015-0232